These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 15967102

  • 1. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
    Bodek G, Vierre S, Rivero-Müller A, Huhtaniemi I, Ziecik AJ, Rahman NA.
    Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
    [Abstract] [Full Text] [Related]

  • 2. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
    Vuorenoja S, Rivero-Müller A, Ziecik AJ, Huhtaniemi I, Toppari J, Rahman NA.
    Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
    [Abstract] [Full Text] [Related]

  • 3. Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.
    Vuorenoja S, Mohanty BP, Arola J, Huhtaniemi I, Toppari J, Rahman NA.
    Endocr Relat Cancer; 2009 Jun; 16(2):549-64. PubMed ID: 19261682
    [Abstract] [Full Text] [Related]

  • 4. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.
    Bodek G, Rahman NA, Zaleska M, Soliymani R, Lankinen H, Hansel W, Huhtaniemi I, Ziecik AJ.
    Breast Cancer Res Treat; 2003 May; 79(1):1-10. PubMed ID: 12779076
    [Abstract] [Full Text] [Related]

  • 5. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.
    Rivero-Müller A, Vuorenoja S, Tuominen M, Wacławik A, Brokken LJ, Ziecik AJ, Huhtaniemi I, Rahman NA.
    Mol Cell Endocrinol; 2007 Apr 15; 269(1-2):17-25. PubMed ID: 17363137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M, Kero J, Nilson JH, Keri RA, Poutanen M, Huhtaniemi I.
    Oncogene; 2003 May 22; 22(21):3269-78. PubMed ID: 12761497
    [Abstract] [Full Text] [Related]

  • 9. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway.
    Bodek G, Kowalczyk A, Waclawik A, Huhtaniemi I, Ziecik AJ.
    Exp Biol Med (Maywood); 2005 Jun 22; 230(6):421-8. PubMed ID: 15956772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting breast and prostate cancers through their hormone receptors.
    Leuschner C, Hansel W.
    Biol Reprod; 2005 Nov 22; 73(5):860-5. PubMed ID: 16033998
    [Abstract] [Full Text] [Related]

  • 15. Hormonal regulation of proliferation of granulosa and Leydig cell lines derived from gonadal tumors of transgenic mice expressing the inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene.
    Rilianawati, Rahman NA, Huhtaniemi I.
    Mol Cell Endocrinol; 1999 Mar 25; 149(1-2):9-17. PubMed ID: 10375013
    [Abstract] [Full Text] [Related]

  • 16. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.
    Leuschner C, Enright FM, Gawronska B, Hansel W.
    Breast Cancer Res Treat; 2003 Mar 25; 78(1):17-27. PubMed ID: 12611453
    [Abstract] [Full Text] [Related]

  • 17. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
    Leuschner C, Enright FM, Gawronska-Kozak B, Hansel W.
    Prostate; 2003 Sep 01; 56(4):239-49. PubMed ID: 12858351
    [Abstract] [Full Text] [Related]

  • 18. Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors.
    Leuschner C, Enright FM, Melrose PA, Hansel W.
    Prostate; 2001 Feb 01; 46(2):116-25. PubMed ID: 11170139
    [Abstract] [Full Text] [Related]

  • 19. Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.
    Hansel W, Enright F, Leuschner C.
    Mol Cell Endocrinol; 2007 Jan 02; 260-262():183-9. PubMed ID: 17101210
    [Abstract] [Full Text] [Related]

  • 20. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Kananen K, Rilianawati, Paukku T, Markkula M, Rainio EM, Huhtaniemi I.
    Endocrinology; 1997 Aug 02; 138(8):3521-31. PubMed ID: 9231807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.